Loading…

Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery

Several essential components of NADPH oxidase, including p22phox, gp91phox (nox2) and its homologs nox1 and nox4, p47phox, p67phox, and rac1, are present in the vasculature. We previously reported that p67phox is essential for adventitial fibroblast NADPH oxidase O2- production. Thus we postulated t...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology. Heart and circulatory physiology 2006-05, Vol.59 (5), p.H1933
Main Authors: Weaver, Mitchell, Liu, Jianhua, Pimentel, David, Reddy, Daniel J
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 5
container_start_page H1933
container_title American journal of physiology. Heart and circulatory physiology
container_volume 59
creator Weaver, Mitchell
Liu, Jianhua
Pimentel, David
Reddy, Daniel J
description Several essential components of NADPH oxidase, including p22phox, gp91phox (nox2) and its homologs nox1 and nox4, p47phox, p67phox, and rac1, are present in the vasculature. We previously reported that p67phox is essential for adventitial fibroblast NADPH oxidase O2- production. Thus we postulated that inhibition of adventitial p67phox activity would attenuate angioplasty-induced hyperplasia. To test this hypothesis, we treated the adventitia of carotid arteries with a control adenovirus (Ad-control), a virus expressing dominant-negative p67phox (Ad-p67dn), or a virus expressing a competitive peptide (gp91ds) targeting the p47phox-gp91phox interaction (Ad-gp91ds). Common carotid arteries (CCAs) from male Sprague-Dawley rats were transfected with Ad-control, Ad-p67dn, or Ad-gp91ds in pluronic gel. After 2 days, a 2-F (Fogarty) catheter was used to injure CCAs in vivo. After 14 days, CCAs were perfusion-fixed and analyzed. In 13 experiments, digital morphometry suggested a reduction of neointimal hyperplasia with Ad-p67dn compared with Ad-control; however, the reduction did not reach statistical significance (P = 0.058). In contrast, a significant reduction was achieved with Ad-gp91ds (P = 0.006). No changes in medial area or remodeling were observed with either treatment. Moreover, adventitial fibroblast proliferation in vitro was inhibited by Ad-gp91ds but not by Ad-p67dn, despite confirmation that Ad-p67dn inhibits NADPH oxidase in fibroblasts. These data appear to suggest that a multicomponent vascular NADPH oxidase plays a role in neointimal hyperplasia. However, inhibition of p47phox may be more effective than inhibition of p67phox at attenuating neointimal growth. [PUBLICATION ABSTRACT]
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_229596950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1037278281</sourcerecordid><originalsourceid>FETCH-proquest_journals_2295969503</originalsourceid><addsrcrecordid>eNqNjEFqwzAQRUVoIW7SOwzZG2QJyXhZQkMO0H0Y6kksY0uqNA7J7atADpDVh__f-ytRNUapujG6exOV1FbXttFmLT5yHqWUprW6EvNXfyXPjh1O0NPkrpTuEM7Qh9l59Fx7uiCXGqJt4xBugMzkF2TK4Cm4Is_FHe6RUpwwO3zoPBAkZPjFFNj1gInL8Va8n3HK9PnMjdgdvn_2xzqm8LdQ5tMYluTLdFKqM53tjNQvQf8hVEu4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229596950</pqid></control><display><type>article</type><title>Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery</title><source>American Physiological Society Free</source><creator>Weaver, Mitchell ; Liu, Jianhua ; Pimentel, David ; Reddy, Daniel J</creator><creatorcontrib>Weaver, Mitchell ; Liu, Jianhua ; Pimentel, David ; Reddy, Daniel J</creatorcontrib><description>Several essential components of NADPH oxidase, including p22phox, gp91phox (nox2) and its homologs nox1 and nox4, p47phox, p67phox, and rac1, are present in the vasculature. We previously reported that p67phox is essential for adventitial fibroblast NADPH oxidase O2- production. Thus we postulated that inhibition of adventitial p67phox activity would attenuate angioplasty-induced hyperplasia. To test this hypothesis, we treated the adventitia of carotid arteries with a control adenovirus (Ad-control), a virus expressing dominant-negative p67phox (Ad-p67dn), or a virus expressing a competitive peptide (gp91ds) targeting the p47phox-gp91phox interaction (Ad-gp91ds). Common carotid arteries (CCAs) from male Sprague-Dawley rats were transfected with Ad-control, Ad-p67dn, or Ad-gp91ds in pluronic gel. After 2 days, a 2-F (Fogarty) catheter was used to injure CCAs in vivo. After 14 days, CCAs were perfusion-fixed and analyzed. In 13 experiments, digital morphometry suggested a reduction of neointimal hyperplasia with Ad-p67dn compared with Ad-control; however, the reduction did not reach statistical significance (P = 0.058). In contrast, a significant reduction was achieved with Ad-gp91ds (P = 0.006). No changes in medial area or remodeling were observed with either treatment. Moreover, adventitial fibroblast proliferation in vitro was inhibited by Ad-gp91ds but not by Ad-p67dn, despite confirmation that Ad-p67dn inhibits NADPH oxidase in fibroblasts. These data appear to suggest that a multicomponent vascular NADPH oxidase plays a role in neointimal hyperplasia. However, inhibition of p47phox may be more effective than inhibition of p67phox at attenuating neointimal growth. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>Bethesda: American Physiological Society</publisher><subject>Peptides ; Rodents ; Veins &amp; arteries</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2006-05, Vol.59 (5), p.H1933</ispartof><rights>Copyright American Physiological Society May 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Weaver, Mitchell</creatorcontrib><creatorcontrib>Liu, Jianhua</creatorcontrib><creatorcontrib>Pimentel, David</creatorcontrib><creatorcontrib>Reddy, Daniel J</creatorcontrib><title>Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery</title><title>American journal of physiology. Heart and circulatory physiology</title><description>Several essential components of NADPH oxidase, including p22phox, gp91phox (nox2) and its homologs nox1 and nox4, p47phox, p67phox, and rac1, are present in the vasculature. We previously reported that p67phox is essential for adventitial fibroblast NADPH oxidase O2- production. Thus we postulated that inhibition of adventitial p67phox activity would attenuate angioplasty-induced hyperplasia. To test this hypothesis, we treated the adventitia of carotid arteries with a control adenovirus (Ad-control), a virus expressing dominant-negative p67phox (Ad-p67dn), or a virus expressing a competitive peptide (gp91ds) targeting the p47phox-gp91phox interaction (Ad-gp91ds). Common carotid arteries (CCAs) from male Sprague-Dawley rats were transfected with Ad-control, Ad-p67dn, or Ad-gp91ds in pluronic gel. After 2 days, a 2-F (Fogarty) catheter was used to injure CCAs in vivo. After 14 days, CCAs were perfusion-fixed and analyzed. In 13 experiments, digital morphometry suggested a reduction of neointimal hyperplasia with Ad-p67dn compared with Ad-control; however, the reduction did not reach statistical significance (P = 0.058). In contrast, a significant reduction was achieved with Ad-gp91ds (P = 0.006). No changes in medial area or remodeling were observed with either treatment. Moreover, adventitial fibroblast proliferation in vitro was inhibited by Ad-gp91ds but not by Ad-p67dn, despite confirmation that Ad-p67dn inhibits NADPH oxidase in fibroblasts. These data appear to suggest that a multicomponent vascular NADPH oxidase plays a role in neointimal hyperplasia. However, inhibition of p47phox may be more effective than inhibition of p67phox at attenuating neointimal growth. [PUBLICATION ABSTRACT]</description><subject>Peptides</subject><subject>Rodents</subject><subject>Veins &amp; arteries</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNjEFqwzAQRUVoIW7SOwzZG2QJyXhZQkMO0H0Y6kksY0uqNA7J7atADpDVh__f-ytRNUapujG6exOV1FbXttFmLT5yHqWUprW6EvNXfyXPjh1O0NPkrpTuEM7Qh9l59Fx7uiCXGqJt4xBugMzkF2TK4Cm4Is_FHe6RUpwwO3zoPBAkZPjFFNj1gInL8Va8n3HK9PnMjdgdvn_2xzqm8LdQ5tMYluTLdFKqM53tjNQvQf8hVEu4</recordid><startdate>20060501</startdate><enddate>20060501</enddate><creator>Weaver, Mitchell</creator><creator>Liu, Jianhua</creator><creator>Pimentel, David</creator><creator>Reddy, Daniel J</creator><general>American Physiological Society</general><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20060501</creationdate><title>Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery</title><author>Weaver, Mitchell ; Liu, Jianhua ; Pimentel, David ; Reddy, Daniel J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2295969503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Peptides</topic><topic>Rodents</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weaver, Mitchell</creatorcontrib><creatorcontrib>Liu, Jianhua</creatorcontrib><creatorcontrib>Pimentel, David</creatorcontrib><creatorcontrib>Reddy, Daniel J</creatorcontrib><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weaver, Mitchell</au><au>Liu, Jianhua</au><au>Pimentel, David</au><au>Reddy, Daniel J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><date>2006-05-01</date><risdate>2006</risdate><volume>59</volume><issue>5</issue><spage>H1933</spage><pages>H1933-</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>Several essential components of NADPH oxidase, including p22phox, gp91phox (nox2) and its homologs nox1 and nox4, p47phox, p67phox, and rac1, are present in the vasculature. We previously reported that p67phox is essential for adventitial fibroblast NADPH oxidase O2- production. Thus we postulated that inhibition of adventitial p67phox activity would attenuate angioplasty-induced hyperplasia. To test this hypothesis, we treated the adventitia of carotid arteries with a control adenovirus (Ad-control), a virus expressing dominant-negative p67phox (Ad-p67dn), or a virus expressing a competitive peptide (gp91ds) targeting the p47phox-gp91phox interaction (Ad-gp91ds). Common carotid arteries (CCAs) from male Sprague-Dawley rats were transfected with Ad-control, Ad-p67dn, or Ad-gp91ds in pluronic gel. After 2 days, a 2-F (Fogarty) catheter was used to injure CCAs in vivo. After 14 days, CCAs were perfusion-fixed and analyzed. In 13 experiments, digital morphometry suggested a reduction of neointimal hyperplasia with Ad-p67dn compared with Ad-control; however, the reduction did not reach statistical significance (P = 0.058). In contrast, a significant reduction was achieved with Ad-gp91ds (P = 0.006). No changes in medial area or remodeling were observed with either treatment. Moreover, adventitial fibroblast proliferation in vitro was inhibited by Ad-gp91ds but not by Ad-p67dn, despite confirmation that Ad-p67dn inhibits NADPH oxidase in fibroblasts. These data appear to suggest that a multicomponent vascular NADPH oxidase plays a role in neointimal hyperplasia. However, inhibition of p47phox may be more effective than inhibition of p67phox at attenuating neointimal growth. [PUBLICATION ABSTRACT]</abstract><cop>Bethesda</cop><pub>American Physiological Society</pub></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2006-05, Vol.59 (5), p.H1933
issn 0363-6135
1522-1539
language eng
recordid cdi_proquest_journals_229596950
source American Physiological Society Free
subjects Peptides
Rodents
Veins & arteries
title Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A25%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adventitial%20delivery%20of%20dominant-negative%20p67phox%20attenuates%20neointimal%20hyperplasia%20of%20the%20rat%20carotid%20artery&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Weaver,%20Mitchell&rft.date=2006-05-01&rft.volume=59&rft.issue=5&rft.spage=H1933&rft.pages=H1933-&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/&rft_dat=%3Cproquest%3E1037278281%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_2295969503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=229596950&rft_id=info:pmid/&rfr_iscdi=true